FI883889A0 - Menetelmä uusien terapeuttisesti käyttökelpoisten aristeromysiini/adenosiinijohdannaisten valmistamiseksi - Google Patents

Menetelmä uusien terapeuttisesti käyttökelpoisten aristeromysiini/adenosiinijohdannaisten valmistamiseksi

Info

Publication number
FI883889A0
FI883889A0 FI883889A FI883889A FI883889A0 FI 883889 A0 FI883889 A0 FI 883889A0 FI 883889 A FI883889 A FI 883889A FI 883889 A FI883889 A FI 883889A FI 883889 A0 FI883889 A0 FI 883889A0
Authority
FI
Finland
Prior art keywords
aristeromycin
preparation
therapeutically useful
adenosine derivatives
new therapeutically
Prior art date
Application number
FI883889A
Other languages
English (en)
Swedish (sv)
Other versions
FI90876B (fi
FI90876C (fi
FI883889A (fi
Inventor
Esa T Jarvi
James R Mccarthy
Nellikunja J Prakash
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of FI883889A0 publication Critical patent/FI883889A0/fi
Publication of FI883889A publication Critical patent/FI883889A/fi
Publication of FI90876B publication Critical patent/FI90876B/fi
Application granted granted Critical
Publication of FI90876C publication Critical patent/FI90876C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/052—Imidazole radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/056—Triazole or tetrazole radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FI883889A 1987-08-26 1988-08-23 Menetelmä uusien terapeuttisesti käyttökelpoisten aristeromysiini/adenosiinijohdannaisten valmistamiseksi FI90876C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8969387A 1987-08-26 1987-08-26
US8969387 1987-08-26

Publications (4)

Publication Number Publication Date
FI883889A0 true FI883889A0 (fi) 1988-08-23
FI883889A FI883889A (fi) 1989-02-27
FI90876B FI90876B (fi) 1993-12-31
FI90876C FI90876C (fi) 1994-04-11

Family

ID=22219090

Family Applications (1)

Application Number Title Priority Date Filing Date
FI883889A FI90876C (fi) 1987-08-26 1988-08-23 Menetelmä uusien terapeuttisesti käyttökelpoisten aristeromysiini/adenosiinijohdannaisten valmistamiseksi

Country Status (22)

Country Link
US (1) US4997924B1 (fi)
EP (1) EP0304889B1 (fi)
JP (1) JP2722215B2 (fi)
KR (1) KR970002660B1 (fi)
CN (1) CN1023561C (fi)
AR (1) AR244229A1 (fi)
AT (1) ATE141282T1 (fi)
AU (1) AU613660B2 (fi)
CA (1) CA1315779C (fi)
DE (1) DE3855470T2 (fi)
DK (1) DK166355C (fi)
ES (1) ES2092981T3 (fi)
FI (1) FI90876C (fi)
GR (1) GR3020849T3 (fi)
HU (1) HU199153B (fi)
IE (1) IE81117B1 (fi)
IL (1) IL87532A (fi)
NO (1) NO168361C (fi)
NZ (1) NZ225906A (fi)
PH (1) PH25533A (fi)
PT (1) PT88340B (fi)
ZA (1) ZA886216B (fi)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4996308A (en) * 1988-03-25 1991-02-26 Merrell Dow Pharmaceuticals Inc. Derivatives with unsaturated substitutions for the 5'-hydroxymethyl group
HU204843B (en) * 1988-09-27 1992-02-28 Merrell Dow Pharma Process for producing 2'-halogen-methylidene adenosine derivatives and pharmaceutical compositions comprising same
JPH02215781A (ja) * 1989-02-14 1990-08-28 Toyo Jozo Co Ltd ６’―デオキシ―６’―ハロゲノネプラノシンａおよびその製造法
JPH03118384A (ja) * 1989-07-24 1991-05-20 Glaxo Group Ltd シクロペンタン誘導体
CA2027023C (en) * 1989-10-11 2001-12-25 Esa T. Jarvi Inosine/guanosine derivatives
AU629988B2 (en) * 1989-10-11 1992-10-15 Merrell Dow Pharmaceuticals Inc. Inosine/guanosine derivatives as antineoplastic agents
ZA908001B (en) * 1989-10-11 1991-08-28 Merrell Dow Pharma Inosine/guanosine derivatives as immunosuppressive agents
DE4005275A1 (de) * 1990-02-20 1991-08-22 Grundmann Ewald Verwendung von s-adenosylmethionin als mittel gegen virale infektionen durch retroviren
JPH0421682A (ja) * 1990-05-11 1992-01-24 Asahi Chem Ind Co Ltd ２―フルオロネプラノシンａおよびその製造法
US5618704A (en) * 1990-07-27 1997-04-08 Isis Pharmacueticals, Inc. Backbone-modified oligonucleotide analogs and preparation thereof through radical coupling
ZA916350B (en) * 1990-08-16 1992-05-27 Merrell Dow Pharma 5'-vinylhalo-aristeromycin/adenosine analogs as immunosuppressants
US5514688A (en) * 1990-09-14 1996-05-07 Merrell Dow Pharmaceuticals Inc. Carbocyclic adenosine analogs useful as immunosuppressants
US5244896A (en) * 1990-09-14 1993-09-14 Marion Merrell Dow Inc. Carbocyclic adenosine analogs useful as immunosuppressants
US5206244A (en) * 1990-10-18 1993-04-27 E. R. Squibb & Sons, Inc. Hydroxymethyl (methylenecyclopentyl) purines and pyrimidines
CA2158462A1 (en) * 1993-03-18 1994-09-29 Akira Matsuda Novel 2'-methylidenenucleotide compounds, methods for production thereof and pharmaceutical use thereof
EP0630897A3 (en) * 1993-06-25 1995-03-01 Bristol Myers Squibb Co 3-hydroxy-4-hydroxymethyl-2-methylene-cyclopentyl purines and pyrimidines.
US6579857B1 (en) 1999-06-11 2003-06-17 Evanston Northwestern Healthcare Research Institute Combination cancer therapy comprising adenosine and deaminase enzyme inhibitors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3928319A (en) * 1971-06-16 1975-12-23 Syntex Inc 4 -Fluoro nucleosides, novel intermediates and methods of preparing same
US3910885A (en) * 1974-03-12 1975-10-07 Syntex Inc 4-Alkoxy nucleosides and intermediates therefore
JPS5651414A (en) * 1979-10-02 1981-05-09 Toyo Jozo Co Ltd Antibiotic substance neplanocin preparation
US4543255A (en) * 1984-05-10 1985-09-24 Southern Research Institute Carbocyclic analogs of purine 2'-deoxyribofuranosides

Also Published As

Publication number Publication date
AR244229A1 (es) 1993-10-29
DE3855470T2 (de) 1997-03-13
DK475488A (da) 1989-02-27
NO883793D0 (no) 1988-08-25
DK166355B (da) 1993-04-13
FI90876B (fi) 1993-12-31
FI90876C (fi) 1994-04-11
CN1023561C (zh) 1994-01-19
NO168361C (no) 1992-02-12
NO168361B (no) 1991-11-04
HU199153B (en) 1990-01-29
EP0304889A3 (en) 1990-01-24
KR890003796A (ko) 1989-04-18
US4997924A (en) 1991-03-05
ATE141282T1 (de) 1996-08-15
CA1315779C (en) 1993-04-06
EP0304889A2 (en) 1989-03-01
DK475488D0 (da) 1988-08-25
NO883793L (no) 1989-02-27
AU2143888A (en) 1989-03-02
JP2722215B2 (ja) 1998-03-04
PH25533A (en) 1991-07-24
IL87532A (en) 1993-05-13
JPH01308267A (ja) 1989-12-12
ES2092981T3 (es) 1996-12-16
FI883889A (fi) 1989-02-27
IE882593L (en) 1989-02-26
GR3020849T3 (en) 1996-11-30
HUT47954A (en) 1989-04-28
DK166355C (da) 1993-09-06
PT88340A (pt) 1989-06-30
KR970002660B1 (en) 1997-03-07
PT88340B (pt) 1995-05-04
DE3855470D1 (de) 1996-09-19
IE81117B1 (en) 2000-03-22
EP0304889B1 (en) 1996-08-14
CN1033632A (zh) 1989-07-05
NZ225906A (en) 1990-10-26
ZA886216B (en) 1989-04-26
US4997924B1 (en) 1995-11-14
AU613660B2 (en) 1991-08-08
IL87532A0 (en) 1989-01-31

Similar Documents

Publication Publication Date Title
FI885943A (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten adenosiinijohdannaisten valmistamiseksi ja välituotteita
FI880941A (fi) Menetelmä terapeuttisesti käyttökelpoisten piperatsinyyli-heterosyklisten yhdisteiden valmistamiseksi
FI905941A (fi) Menetelmä terapeuttisesti käyttökelpoisten heterosyklisten 2-asyyliaminotiatsolijohdannaisten valmistamiseksi
FI97297C (fi) Menetelmä terapeuttisesti käyttökelpoisten booriaminohappojohdannaisten valmistamiseksi
FI883064A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten heterosyklisten yhdisteiden valmistamiseksi
FI874459A (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten piperidiinijohdannaisten valmistamiseksi
FI850654L (fi) Menetelmä terapeuttisesti käyttökelpoisten pleuromutilinijohdannaisten valmistamiseksi
FI891339A0 (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten aristeromysiini/adenosiinijohdannaisten valmistamiseksi
FI883889A (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten aristeromysiini/adenosiinijohdannaisten valmistamiseksi
PT87191A (pt) Process for the preparation of nucleosides
FI890286A (fi) Menetelmä terapeuttisesti käyttökelpoisten dideoksikarbosyklisten nukleosidianalogien valmistamiseksi
FI895417A0 (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten 2'-halometylideeninukleosidien valmistamiseksi
FI92696C (fi) Menetelmä terapeuttisesti käyttökelpoisten tiatsolidiinidionijohdannaisten valmistamiseksi
FI872517A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten makrolidiyhdisteiden valmistamiseksi
FI883672A (fi) Menetelmä terapeuttisesti käyttökelpoisten aminoalkoksifenyylijohdannaisten valmistamiseksi
FI883997A (fi) Menetelmä terapeuttisesti käyttökelpoisten substituoitujen 2-fenyyli-4-kinoliinikarboksyylihappojen valmistamiseksi
FI895393A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten alkyylisubstituoitujen 2-alkyyliamiinibentsopyran-6-olien valmistamiseksi
FI880467A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten substituoitujen 3,4-dihydro-2H-bentsopyraanien valmistamiseksi
FI873350A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten 1,4-dihydropyridiinijohdannaisten valmistamiseksi
FI893003A (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten neplanosiinijohdannaisten valmistamiseksi
FI92064C (fi) Menetelmä terapeuttisesti käyttökelpoisten N-bentsopyranyylilaktaamien valmistamiseksi
FI884473A (fi) Menetelmä terapeuttisesti käyttökelpoisten fenoksialkyylipyrokatekolijohdannaisten valmistamiseksi
FI892420A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten 2-aminoetanolijohdannaisten valmistamiseksi
FI863471A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten 3-desmetyylimevalonihappojohdannaisten valmistamiseksi
PT87705A (pt) Process for the preparation of 6-deoxy guanine derivative

Legal Events

Date Code Title Description
BB Publication of examined application
MM Patent lapsed

Owner name: MERRELL DOW PHARMACEUTICALS INC.